HIF-1a is downstream of the PI3K/AKT/mammalian target of rapamycin (mTOR) pathway and is associated with the progression of myeloma cells through the transcription of several important genes concerning myeloma pathogenesis, such as VEGF and IGF-1 [81]. This evidence concerns the gene VEGFA and plasma cell myeloma.